Complex Neurological Phenotype Associated with a De Novo DHDDS Mutation in a Boy with Intellectual Disability, Refractory Epilepsy, and Movement Disorder

Abstract

Mutations in the DHDDS gene (MIM: 617836), encoding a subunit of dehydrodolichyl diphosphate synthase complex, have been recently implicated in very rare neurodevelopmental diseases. In total, five individuals carrying two de novo mutations in DHDDS have been reported so far, but genotype–phenotype correlations remain elusive. We reported a boy with a de novo mutation in DHDDS (NM_205861.3: c.G632A; p.Arg211Gln) featuring a complex neurological phenotype, including mild intellectual disability, impaired speech, complex hyperkinetic movements, and refractory epilepsy. We defined the electroclinical and movement disorder phenotype associated with the monoallelic form of the DHDDS-related neurodevelopmental disease and possible underlying dominant-negative mechanisms.

Keywords

DHDDS - neurodevelopmental disorder - epilepsy

Authors' Contributions

G.P. performed study design and experimental data acquisition, analysis, and interpretation of data for this study. E.A., M.S.V., and V.G. conceptualized the study, helped acquire clinical data, contributed to the manuscript, analyzed and interpreted phenotype data. M.I. contributed to the manuscript, and helped in analysis and interpretation of genetic data. F.M.V.S. performed critical revision of the manuscript document. P.S. and F.Z. supervised the study and obtained funding.

Consent for Publication

Written consent for recording and publishing photographs and videos of the patient were obtained from his parents.

Publikationsverlauf

Eingereicht: 24. April 2020

Angenommen: 08. Mai 2020

Artikel online veröffentlicht:
31. Juli 2020

• References

• 1 Salpietro V, Malintan NT, Llano-Rivas I. et al; Deciphering Developmental Disorders Study; SYNAPS Study Group. Mutations in the neuronal vesicular SNARE VAMP2 affect synaptic membrane fusion and impair human neurodevelopment. Am J Hum Genet 2019; 104 (04) 721-730
• 2 Salpietro V, Dixon CL, Guo H. et al; SYNAPS Study Group. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders. Nat Commun 2019; 10 (01) 3094
• 3 Sabry S, Vuillaumier-Barrot S, Mintet E. et al. A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity. Orphanet J Rare Dis 2016; 11 (01) 84
• 4 Lisnyansky Bar-El M, Lee SY, Ki AY. et al. Structural characterization of full-length human dehydrodolichyl diphosphate synthase using an integrative computational and experimental approach. Biomolecules 2019; 9 (11) 660
• 5 Grabińska KA, Park EJ, Sessa WC. CIS-prenyltransferase: new insights into protein glycosylation, rubber synthesis, and human diseases. J Biol Chem 2016; 291 (35) 18582-18590
• 6 Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science 2001; 291 (5512): 2364-2369
• 7 Ng BG, Freeze HH. Perspectives on glycosylation and its congenital disorders. Trends Genet 2018; 34 (06) 466-476
• 8 Fiumara A, Barone R, Del Campo G, Striano P, Jaeken J. Electroclinical features of early-onset epileptic encephalopathies in congenital disorders of glycosylation (CDGs). JIMD Rep 2016; 27: 93-99
• 9 Freeze HH. Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem 2013; 288 (10) 6936-6945
• 10 Hamdan FF, Myers CT, Cossette P. et al; Deciphering Developmental Disorders Study. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet 2017; 101 (05) 664-685